Skip to main content

    Main navigation

    • Investors
    • About
    • News
    • Contact us
    • Egoo.health
    • en
    • sv
Home

Main navigation

  • Investors
  • About
  • News
  • Contact us
  • Egoo.health
  • en
  • sv
 

Investors

+

Main navigation

Main navigation

  • News - Press releases
  • Financial Calendar
  • Financial reports
    • IPO and listning documents
  • Corporate governance
    • Articles Of Association
    • AGM and Extraordinary general meetings
      • Annual General Meeting on May 5 2022
      • Annual general meeting on 5 May 2021
      • Extraordinary Shareholders Meeting 19 November
      • Extraordinary general meeting January 2020
      • Annual General Meeting, May 20, 2020
    • Auditor
    • Nomination Committee
    • Certified adviser
  • Share information
    • Major shareholders
    • Sharecapital
    • Incentive programme
    • Dividend Policy
    • Warrants (TO)
  • Board
  • Management
  • Insiders
  • IR Contact
  • Presentations

Major shareholders

The largest shareholders in Qlife Holding AB as per 31 December 2021.

Name Number of shares %
BNY Mellon SA/NV, Belgium   3 658 563 23.6%
JP Morgan Chase Bank NA   1 220 150   7.9%
Försäkringsbolaget Avanza Pension      832 532   5.4%
Fjärde AP-Fonden      740 000   4.8%
Nordnet Pensionsförsäkring      278 827   1.8%
Leif Jonsson      250 000   1.6%
Societe General Nantes      238 100   1.5%
KMD Venture A/S      163 216   1.1%
John Andersson Moll      107 874   0.7%
Mikael Gunnarsson      100 000   0.6%
Others   7 895 665  51.0%
Sum 15 484 927 100%

According to public nominee register of shareholders register from Euroclear.

Qlife

Qlife Holding AB
Redaregatan 48
SE-252 36 Helsingborg, Sweden
info@egoo.health

Links

  • About
  • Investors
  • Egoo.health

Qlife Holding AB is a med-tech group that strives to revolutionize the market for clinical biomarker and virus tests. By enabling tests at home as a complement to tests in healthcare, access to important health information that can contribute to better treatment and potential prevention of diseases is facilitated. On March 2, 2020, Qlife Holding completed a listing on the Nasdaq First North Growth Market, Stockholm. The company currently has about 40 employees.